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Analysis of High-Resolution HapMap of DTNBP1 (Dysbindin)
Suggests No Consistency between Reported Common Variant
Associations and Schizophrenia
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and Pamela Sklar
DTNBP1 was ﬁrst identiﬁed as a putative schizophrenia-susceptibility gene in Irish pedigrees, with a report of association
to common genetic variation. Several replication studies have reported conﬁrmation of an association to DTNBP1 in
independent European samples; however, reported risk alleles and haplotypes appear to differ between studies, and
comparison among studies has been confounded because different marker sets were employed by each group. To facilitate
evaluation of existing evidence of association and further work, we supplemented the extensive genotype data, available
through the International HapMap Project (HapMap), aboutDTNBP1 by speciﬁcally typing all associated single-nucleotide
polymorphisms reported in each of the studies of the Centre d’E´tude du PolymorphismeHumain (CEPH)–derivedHapMap
sample (CEU). Using this high-density reference map, we compared the putative disease-associated haplotype from each
study and found that the association studies are inconsistent with regard to the identity of the disease-associatedhaplotype
at DTNBP1. Speciﬁcally, all ﬁve “replication” studies deﬁne a positively associated haplotype that is different from the
association originally reported. We further demonstrate that, in all six studies, the European-derived populations studied
have haplotype patterns and frequencies that are consistent with HapMap CEU samples (and each other). Thus, it is
unlikely that population differences are creating the inconsistency of the association studies. Evidence of association is,
at present, equivocal and unsatisfactory. The new dense map of the region may be valuable in more-comprehensive
follow-up studies.
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Schizophrenia (SCZ [MIM 181500]) is a common psychi-
atric disorder, with a lifetime morbidity risk of 0.72%,1
that presents with psychotic symptoms (delusions and
hallucinations), thought disorder, and deﬁcit features de-
scribed as “negative” symptoms. Although SCZ is highly
heritable,2 the genetic etiology is complex, and identiﬁ-
cation of replicable susceptibility genes has proved difﬁ-
cult.3 A number of SCZ-susceptibility genes have nowbeen
reported (see the review by Owen et al.3). One of the most
prominent of these genes is the dystrobrevin binding pro-
tein 1 gene (DTNBP1 [MIM 607145]) on 6p22.3, which
encodes the dysbindin protein. DTNBP1 was ﬁrst identi-
ﬁed as an SCZ-susceptibility gene in SCZ-affected Irish
pedigrees.4,5 These data were later reanalyzed, and the
association signal was attributed to a haplotype of low
frequency (0.058)—deﬁned as G-G-A-A-T-G-C-G on the
minus strand of SNPs rs3213207, rs1011313, rs2619528,
rs2005976, rs760761, rs2619522, rs1018381, and rs1474605—
at the locus (see table 4 in the work of van den Oord et
al.6). Schwab and colleagues next reported association at
DTNBP1 in sib pairs and parents-proband trios from Ger-
many, Hungary, and Israel.7 In that study, the strongest
evidence of association came from themost commonhap-
lotype across the “associated” region, as determined by
van den Oord et al.6 Although not formally tested, the
low-frequency haplotype that was associated in the study
by van den Oord et al.6 shows evidence of undertrans-
mission in the sample of Schwab et al.7 A series of sub-
sequent studies also purported to replicate association
between DTNBP1 and SCZ in family-based8,9 and popu-
lation-based samples.10–14 In our “Material and Methods”
section, we detail the association ﬁndings from these stud-
ies. To date, these association studies, either individually
or in combination, have not identiﬁed the causal vari-
ant(s) at DTNBP1 that contribute to SCZ risk. However,
there is some evidence to suggest that DTNBP1 expres-
sion is altered in the brain of patients with SCZ, although
no consistent haplotype has been associated with these
changes.15,16
A major difﬁculty in interpretation of the results from
DTNBP1-association studies is that the same SNPs have
not been genotyped in all studies, which precludes direct
comparison of risk alleles and haplotypes. Furthermore,
where positive ﬁndings have been reported using the same
SNP, there are instances in which the associated allele dif-
fers among samples. This has been attributed to potential
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Table 1. SNP Ampliﬁcation and Extension-
Primer Sequences
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
differences in the genetic architecture of the sampled
populations.
Here, we sought to address these problems by using data
generated as part of the International HapMap Project
(HapMap).17 To make studies directly comparable, we ge-
notyped all SNPs from the DTNBP1-association studies in
the CEPH-derived trios employed by HapMap, and we
made a composite haplotype map for this locus, to eval-
uate the similarity of SNP and haplotype frequencies in
the populations that were sampled in theDTNBP1 studies.
We have considered only data from studies of samples
ascertained from populations of European ancestry. This
allows appraisal of the degree of similarity of local linkage-
disequilibrium (LD) structure at DTNBP1 among the dif-
ferent European samples and determination of whether
this is a contributing factor to the differences observed in
reported associations.
Material and Methods
SNP Selection for Genotyping and Analysis
SNPs were selected from three sources: previous association stud-
ies of DTNBP1, dbSNP, and phase II of HapMap.
Previously Associated SNPs.—We identiﬁed all SNPs reported in
six association studies of DTNBP1 and SCZ that used samples of
European-derived ancestry ( SNPs).5–7,9,10,12,18 Of thosenp 31
SNPs, 26 were genotyped in our lab, 3 SNPs (rs2619539,
rs1474605, and rs1997679) had already been genotyped as part
of phase I of HapMap, 1 marker (SNP N) was a rare 1-base inser-
tion/deletion not associated with SCZ in the original study,18 and
1 SNP (SNP O) was rare and also was not associated with SCZ in
the original paper.18 Of the associated SNPs that were genotyped
in our lab, 12 (rs12524251, rs2005976, rs909706, rs2743852,
rs742105, rs16876738, rs13198335, rs13198195, rs2619542,
rs2619550, rs2619537, and rs12204704) were not available as part
of the HapMap data release 19 (HapMap).
dbSNP.—Before the availability of phase II of the HapMap data,
we selected an additional 63 SNPs from across the DTNBP1 gene
and 10 kb upstream and downstream from those included in
dbSNP (see CHIP Bioinformatics Tools Web site). Thus, there was
a total of 89 SNPs genotyped. These SNPs were genotyped in the
CEPH-derived HapMap (CEU) trio samples ( trios) used asnp 30
part of the HapMap Project (Coriell Institute Cell Repository).
Phase II HapMap SNPs.—Subsequently, all SNPs available from
HapMap phase II (HapMap data release 19; phase II of theOctober
2005 National Center for Biotechnology Information [NCBI]
build 34 assembly; dbSNP build 124) across theDTNBP1 gene and
10 kb upstream and downstream were selected. There was a total
of 214 SNPs. Of those, 61 were monomorphic, 5 had genotyping
call rates !90%, and 1 SNP had signiﬁcant discrepancies with our
genotyping; those 67 SNPs were not included in further analyses.
SNP Genotyping
Genotyping was performed by mass spectrometry as described
elsewhere,19 with use of ampliﬁcation and extension primers de-
signed by Spectro-Designer software (Sequenom). For each SNP,
genotype data that met the following quality-control metrics
were considered for analysis: (1) 190% of DNA samples attempted
for genotyping per SNP were obtained, (2) !1% of chromosomes
from parents to probands had Mendelian inheritance errors, (3)
parental alleles were in Hardy-Weinberg equilibrium, and (4) a
minor-allele frequency of 11%. SNP primer sequences are listed
in table 1.
Of the 89 SNPs we genotyped, 36 were not included in the
subsequent analyses (minor-allele frequency !1% [ ]; ge-np 26
notyping call rate !90% [ ]; Hardy-Weinberg violationnp 5
[ ]). One further SNP (rs1988856) was eliminated, since 35%np 4
of the genotypes differed from those in HapMap. (None of the
26 SNPs from the literature failed.) Of the remaining 53 SNPs,
the average genotyping success rate was 98.9%. There were only
two SNPs with genotyping success rates between 90% and 95%.
Since a number of these SNPs were genotyped independently by
HapMap, we were able to compare genotypes, to estimate a con-
cordance rate of our genotyping with that of HapMap. A total of
3,059 SNP genotypes in 36 SNPs were available for comparison,
in which there were 5 discordant genotypes (0.163%).
Production of a Joined Data Set
Genotypes from the 53 SNPs were joined with genotypes from
phase II of HapMap. When a SNP was genotyped in our lab, it
was used in the ﬁnal analysis, to avoid errors in strandedness. A
total of 166 SNPs were used to build the LDmap and to determine
tagging SNPs (tSNPs) for the entire region, with use of Haploview
version 3.3220 and the Tagger implementation therein.
Identiﬁcation of Associated SNPs or Haplotypes in Published
Studies of SCZ and DTNBP1
For this study, we concentrated on association studies ofDTNBP1
and SCZ in European-derived samples (table 2). Within each
study, we identiﬁed the single-marker or multimarker haplotype
result that best captured the association signal in each sample.
We paid particular attention to determining which SNPs tagged
the associated haplotypes reported in the original study; this
would later simplify the task of amalgamating independent ﬁnd-
ings for a common analysis. Across the six studies, only 11 SNPs
were required to deﬁne all associated alleles or haplotypes (table
3). Associated haplotypes from each of the studies are shown in
bold type in table 3, with tSNPs identiﬁed by shading. These tSNPs
are shown in ﬁgure 1. For each of the studies, we identiﬁed the
strongest evidence of association for the following alleles or hap-
lotypes: Kirov et al.9 (study A) found strongest association, in their
sample, with allele A of SNP 2 (rs3213207). The associated hap-
lotype reported by Williams et al.18 (study B) in their United King-
dom and Ireland sample was later redeﬁned by Bray et al.21 as A-
A-T at SNPs 1-2-11. This haplotype can effectively be tagged by
allele T at SNP 11 (rs2619538). Schwab et al.7 (study C) reported
their strongest ﬁnding from the A-G-G-C-T-C haplotype at SNPs
2-3-4-6-7-8. This haplotype can be tagged by the G-C haplotype
from SNPs 3–6 (rs1011313–rs760761). The data from the original
study by Straub et al.5 (study D) was later reanalyzed by van den
Oord et al.,6 who identiﬁed the strongest evidence of association
as coming from the G-G-A-A-T-G-C-G haplotype at SNPs 2-3-4-
5-6-7-8-9. This haplotype can be tagged by the A-C haplotype
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Table 2. Studies Reporting Association of DTNBP1 with SCZ in European-Derived Samples
Study Reference Sample Size and Type Sample Origin
A Kirov et al.9 488 Parents-proband trios Bulgaria
B Williams et al.18; Bray et al.24 708 Cases and 711 controls United Kingdom and Ireland
C Schwab et al.7 78 Sib-pair families and 125 triads (affected proband and parents) Germany, Hungary, and Israel
D Straub et al.4,5; van den Oord et al.6 268 Multiplex families (1,405 individuals genotyped) Ireland
E Van Den Bogaert et al.10 418 German cases and 285 German controls; 142 Swedish cases and
272 Swedish controls; 294 Polish cases and 113 Polish controls
Germany, Sweden, and Poland
F Funke at al.12 258 White cases and 467 white controls United States
from SNPs 5–8 (rs2005976–rs1018381). Van Den Bogaert et al.10
(study E) reported their strongest ﬁnding with the A-G-A-T-T hap-
lotype from SNPs 2-3-5-6-8. This haplotype can be tagged by allele
T at SNP 8 (rs1018381). Funke et al.12 (study F) reported their
strongest ﬁnding with the G-A-G-T-G-T-G haplotype from SNPs
2-3-4-5-6-7-9. This haplotype can be tagged by allele T at SNP 8
(rs1018381). Haplotype frequencies for table 3 in the CEU were
calculated using Haploview.20 For these haplotype frequencies,
the 95% CIs in the CEU were calculated using the method of
Clopper and Pearson.22 A phylogenetic tree was derived for
DTNBP1. A simple series of mutations, excluding backmutations,
homoplasy (the same mutation occurring twice), or recombina-
tion explained the likely evolution of the haplotypes at this locus.
Structure of LD at DTNBP1
With use of the joined set of markers consisting of the three
original categories, an LD map was constructed using Haplo-
view.20 Markers were used to construct an LD map from the 172
SNPs that were present in allele frequencies 11%. A map of hap-
lotypes present at frequency 12% is shown in ﬁgure 2. Graphic
representation of the LD structure (ﬁg. 2) was created by
LocusView version 2.0. To construct a common set of markers
that could be used to investigate the full haplotype structure of
DTNBP1, we used the program Tagger23 (Haploview). Tagger em-
ploys both pairwise and effective (multimarker) haplotype pre-
dictors to capture alleles of interest. We used an threshold of2r
0.8, a LOD score of 3.0, and the “pairwise” option for tSNP se-
lection. A list of tSNPs is shown in table 4.
Results
Comparison of the CEU Allele and Haplotype Frequencies for
All Associated SNPs in the Literature
The sample size and population origin for association
studies of DTNBP1 are presented in table 2. There are six
studies of the association of DTNBP1 and SCZ that have
used samples of European ancestry. In general, there was
not a common set of SNPs genotyped uniformly across all
studies, which makes it impossible to make direct com-
parisons of allele frequencies between or among the stud-
ies. This literature contains 11 SNPs that contribute to the
ﬁnding of either a SNP or haplotype association in at least
one study (table 3). The allele frequencies of these 11 SNPs
were determined in the CEU samples that were used as
part of the International HapMap Project. Across all six
studies of DTNBP1 and SCZ, the haplotypes reported in
each study sample are present in the CEU sample andwith
broadly similar frequencies. This suggests that the LD
structure is very similar across all study samples at this
locus.
Mapping of Associated Markers onto a Common Framework
Map
It was apparent that a smaller set of markers could be used
to tag the associated haplotype in each study. For each
study, table 3 shows the haplotypes in bold type, and the
tSNP(s) for each study are shaded. With the deﬁned as-
sociated alleles or haplotypes from each sample, we then
mapped each of these associated alleles or haplotypes onto
the CEU sample as a reference, to examine all of the stud-
ies together. For this analysis, we concentrated on the
tSNPs from each study, as deﬁned above (SNPs 2, 3, 5, 6,
7, and 11). From these six SNPs, we identiﬁed ﬁve com-
mon haplotypes in the CEU trios. A simple phylogenetic
tree explains the likely evolution of these haplotypes from
an ancestral haplotype. Figure 1A displays this tree and
identiﬁes the ﬁve common CEU haplotypes and their re-
spective frequencies. The ancestral haplotype remains the
most common haplotype.
Comparison of Association Results through Mapping
onto a Common Framework Map
We were then able to map the associated allele or hap-
lotype from each study onto the phylogenetic tree (ﬁg.
1B). The associated allele from the study of Kirov et al.9
(allele A of SNP 2) maps onto haplotypes 1, 2, 4, and 5 in
the CEU data. The allele that tags the associatedhaplotype
in the studies of Williams et al.11,24 (allele T at SNP 11)
maps onto haplotypes 2 and 5. The associated haplotype
from the study of Schwab et al.7 (captured by the haplo-
type G-C at SNPs 3–6) maps onto haplotypes 1 and 2. The
associated haplotype from the study of van den Oord et
al.6 (captured by the haplotype A-C at SNPs 5–8) maps
onto haplotype 3. The strongest association signals from
the studies of both Van Den Bogaert et al.10 and Funke et
al.12 are tagged by allele T at SNP 8; this maps onto hap-
lotype 4.
Construction of a Dense LD Map of DTNBP1
We concentrated our examination on the 160-kb region
on chromosome 6 (nucleotide positions 15621461–
15780272) that contains the DTNBP1 gene (ﬁg. 2), in-
cluding 10–15 kb upstream and downstream. With use of
Table 3. SNPs Reported at DTNBP1 That Contribute to Finding of Association in at Least One Study
SNP Allele Haplotype Frequency in
1 2 3 4 5 6 7 8 9 10 11 CEU (95% CI)
Original
Study
dbSNP ID rs1047631 rs3213207 rs1011313 rs2619528 rs2005976 rs760761 rs2619522 rs1018381 rs1474605 rs909706 rs2619538
Alternative name … P1635 P1325 P1765 P1757 P1320 P1763 P1578 P1792 P1583 SNP A
Chromosome 6 location 15631080 15736081 15741411 15757808 15758781 15759111 15761628 15765049 15766191 15768850 15773188
Allelesa A/G A/G A/G A/G A/G C/T G/T C/T A/G A/G A/T
Study:
A (Kirov et al.9) A .881 (.812–.935) .895b
G .119 (.065–.188) .105
B (Bray et al.24) A A A .398 (.312–.493) .438c
A A T .392 (.304–.485) .404
G G A .108 (.059–.178) .079
G A A .093 (.047–.158) .043
C (Schwab et al.7) A G G C T C .75 (.663–.824) .738d
G G A T G C .108 (.059–.178) .090
A G A T G T .075 (.035–.138) .071
A A G C T C .058 (.024–.116) .061
D (van den Oord et al.6) A G G G C T C A .750 (.663–.824) .733e
G G A A T G C G .108 (.059–.178) .058
A G A A T G T G .075 (.035–.138) .06
A A G G C T C A .058 (.024–.116) .071
G A G G T T C G .008 (.000–.046) .015
E (Van Den Bogaert et al.10) A G G C C .750 (.663–.824) .753f
G G A T C .108 (.059–.178) .094
A G A T T .075 (.035–.138) .031
A A G C C .058 (.024–.116) .060
F (Funke et al.12) A G G C T C G .450 (.359–.543) .499c
A G G C T C A .300 (.220–.390) .266
G G A T G C G .110 (.059–.178) .082
A G A T G T G .075 (.035–.138) .071
A A A C T C A .058 (.024–.116) .065
NOTE.—tSNPs are shaded, and the associated haplotypes from the original studies are shown in bold type.
a Alleles called on the minus strand.
b Frequency in patients with SCZ.
c Frequency in control sample.
d Frequency of transmitted haplotypes in triads.
e Frequency in full sample.
f Frequency in control sample from Sweden.
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Figure 1. A, Phylogenetic tree detailing the likely evolution of the ﬁve common haplotypes derived from tSNPs 2, 3, 5, 6, 8, and 11
(see table 3) in the CEU sample. Haplotype frequencies are shown at the bottom of the tree. Mutational events are detailed on the
horizontal lines of the tree. The ancestral haplotype remains the most common haplotype in the CEU sample. Hap p haplotype. B,
Each associated allele or haplotype from the six association studies of DTNBP1 and SCZ, mapped onto the phylogenetic tree. tSNPs are
shown in parentheses, and haplotypes are shown in brackets.
Figure 2. LD and haplotype-block structure of the DTNBP1 gene.
The legend is available in its entirety in the online edition of The
American Journal of Human Genetics.
our joined data set, there are 166 genotyped SNPs in this
region that have a minor-allele frequency of 11%, for an
average density of 1 SNP per 962 bases. The largest gap
between SNPs is 4.58 kb. There are 10 gaps 13 kb. To pro-
vide a visualization of this region, we used the block def-
inition that deﬁnes strong LD as in the work of Gabriel
et al.,25 and we found that this region comprises six blocks.
Most of the blocks are small; however, there is one large
block, spanning 123 kb, that includes exons 4–7. The LD
between pairs of blocks is very high; for example, it is 0.89
between blocks 1 and 2 and 1.00 between blocks 2 and 3,
3 and 4, and 4 and 5. We used the program Tagger (Hap-
loview) to select a reduced set of tSNPs for this region.
Tagger (Haploview) does not explicitly use haplotype
blocks for tagging; rather, it selects a reduced set of SNPs
on the basis of its ability to represent variation present at
the larger set of SNPs under preset conditions. Because the
11 SNPs reported in the present study have already been
used by many researchers, Tagger (Haploview) has in-
cluded all of these SNPs. With use of pairwise tagging, a
total of 42 SNPs are needed to capture 100% of alleles with
(mean ) across the region covering2 2r 1 0.8 r p 0.975
DTNBP1 (table 4).
Discussion
In the human genome, 19 million SNPs have been re-
ported,26 which yields an abundance of markers to use to
scan the human genome for disease mutations. Since
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Table 4. SNPs and tSNPs in LD Map
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
many of these SNPs have a high degree of allelic associ-
ation with each other, a reduced set of variation can be
used to capture, or tag, genetic variation across a particular
gene. However, since many tSNPs are equivalent for this
purpose, individual investigators have not always chosen
the same markers, so the same small representative set of
SNPs has not been used consistently in all studies of a
given gene. This is the case for DTNBP1, for which studies
have reported association with SCZ in samples of Euro-
pean-derived ancestry.5–7,9,10,12,18 We focused on these stud-
ies and used the CEU trios from HapMap, so that alleles
and haplotypes could be mapped in samples of similar
ancestry. Using this map, we evaluated the evidence in
support of DTNBP1 as an SCZ-susceptibility gene and
found that evidence for DTNBP1 is equivocal.
For each of the six SCZ-association studies of DTNBP1,
the SNPs or haplotypes are of similar frequency in the
association samples and in the CEU sample—this suggests
that each European-derived sample is genetically similar
and that population stratiﬁcation cannot explain differ-
ences in published results. It was not possible to study this
topic in greater detail, because LDmeasurements were not
routinely published for all analyzed SNPs in each study.
When each DTNBP1 study result is reduced to a tSNP or
haplotype that deﬁnes the strongest association signal
studied in that sample, it is possible tomap all results onto
the common haplotypes that are deﬁned by the same
tSNPs in the CEU sample. The simple phylogenetic tree
explains the evolution of these haplotypes. Thephylogeny
of haplotypes was examined by van den Oord et al.6 Al-
though our phylogenetic tree was not determined by com-
puter software, it is essentially identical to the phylogram
of haplotypes from Irish pedigrees that is presented in
ﬁgure 1 of the work by van den Oord et al.6 In both their
study and ours, the ancestral haplotype is the most com-
mon haplotype (van den Oord and colleagues6 did not
genotype rs2619538 [SNP 11], which differentiates hap-
lotypes 1 and 2 in our study). However, there are two low-
frequency (!2%) haplotypes in the Irish sample that were
not associated with SCZ that are not detected in the CEU
sample. Haplotype frequencies are very similar in both our
studies and the study by van den Oord et al.6 Frequencies
differ by no more than 1.5%, with the exception of the
Irish-associated haplotype (haplotype 2 in the work of van
den Oord et al.6), which has a frequency of 5.8% in the
Irish families, compared with a frequency of 10.8% in the
CEU sample (haplotype 3 in the present study).
We have demonstrated that each common DTNBP1
haplotype is tagged by the association signal of at least
one study, which implies that there is not one common
causal variant that is contributing to SCZ risk at the
DTNBP1 locus. There are a number of caveats to be aware
of in interpreting the results of the present study. First,
this study does not represent a true meta-analysis, since
we did not have access to raw genotypes from each com-
pleted study of DTNBP1. We could rely only on the pub-
lished ﬁndings of each study, and we concentrated spe-
ciﬁcally on only one association result from each study.
Second, it is possible that only some of the studies have
produced false-positive results but that there is some
agreement among studies. This is not something that can
be evaluated given the current data. Third, differences in
environmental factors, ascertainment schemes, and di-
agnosis could lead to different results. Furthermore, the
samples were of varying size, type, and degrees of statis-
tical power as replication samples. Our study does not rule
out the possibility of an appreciable number of rare var-
iants that have arisen on multiple common backgrounds.
However, the spectrum of rare penetrant variation would
not be expected to result in highly signiﬁcant associations
with multiple common haplotypes. Therefore, in the ab-
sence of a common causal variant and without raw ge-
notypic and phenotypic data from these large samples, it
is impossible to tease out subtle inﬂuence on the SCZ phe-
notype of genetic variants at DTNBP1.
All studies (European-derived populations) had allele or
haplotype frequencies compatible with the HapMap CEU
sample. The present study has shown the utility of
HapMap in successfully relating association studies that
have used diverse marker sets and, furthermore, empha-
sizes the utility of testing a common set of SNPs, to enable
direct comparisons between or among association studies.
Because we ﬁnd that all of the association samples of Eu-
ropean-derived ancestry have a similar genetic structure,
the conﬂicting results among studies cannot simply be
attributed to population differences. This calls into ques-
tion the interpretation of the replication studies at this
locus. Although a large number of studies have reported
association of DTNBP1 with SCZ, it is important to un-
ambiguously conﬁrm this association and to identify the
risk alleles. We have produced a dense genetic map and a
list of tSNPs of the region that can now be used for large-
scale association studies, to help determine how DTNBP1
contributes to SCZ susceptibility.
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